Suppr超能文献

劳卡尼(R 15889)对人体的电生理效应

[Electrophysiologic effects of lorcainide (R 15889) in man].

作者信息

Touboul P, Atallah G, Kirkorian G

出版信息

Arch Mal Coeur Vaiss. 1981 Nov;74(11):1333-40.

PMID:6797372
Abstract

The electrophysiological effects of lorcainide (R 15 899) were studied in 15 patients. Atrioventricular conduction was analysed by His bundle recording and cardiac refractory periods were determined by the extra stimulus method. The assessment of sino atrial function was performed by measuring sinus node recovery times and sino atrial conduction times. The electrophysiological data was recorded before and 10 minutes after a slow intravenous injection of 1,5 mg/Kg of lorcainide followed by a continuous infusion at 0,02 mg/Kg/min. The following results were obtained; 1) The HV interval increased in all cases (average : II ms) 2) The QRS and QT intervals were significantly prolonged 3) Lorcainide produced a slowing of conduction and an increase in the refractory periods at atrial level 4) AV nodal conduction was unaffected 5) The sinus rate slightly increased. There were no significant changes in sinus node recovery time or sino atrial conduction. It must be concluded that, in man, lorcainide produces electrophysiological effects of antiarrhythmic agents of the quinidine type.

摘要

对15例患者研究了劳卡尼(R 15 899)的电生理效应。通过希氏束记录分析房室传导,并用额外刺激法测定心脏不应期。通过测量窦房结恢复时间和窦房传导时间来评估窦房功能。在缓慢静脉注射1.5mg/kg劳卡尼,随后以0.02mg/kg/min持续输注之前和之后10分钟记录电生理数据。获得以下结果:1)所有病例的HV间期均增加(平均:11ms);2)QRS和QT间期显著延长;3)劳卡尼使心房水平的传导减慢和不应期延长;4)房室结传导未受影响;5)窦性心率略有增加。窦房结恢复时间或窦房传导无显著变化。必须得出结论,在人体中,劳卡尼产生奎尼丁类型抗心律失常药物的电生理效应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验